On Monday, Esperion Therapeutics Inc (NASDAQ: ESPR) opened higher 7.01% from the last session, before settling in for the closing price of $2.71. Price fluctuations for ESPR have ranged from $0.69 to $3.94 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 40.11%. Company’s average yearly earnings per share was noted 70.30% at the time writing. With a float of $226.57 million, this company’s outstanding shares have now reached $231.62 million.
Esperion Therapeutics Inc (ESPR) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Esperion Therapeutics Inc is 2.18%, while institutional ownership is 50.50%. The most recent insider transaction that took place on Oct 17 ’25, was worth 3,275. Before that another transaction happened on Sep 17 ’25, when Company’s General Counsel sold 6,267 for $2.80, making the entire transaction worth $17,573. This insider now owns 393,670 shares in total.
Esperion Therapeutics Inc (ESPR) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.15 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.17) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.30% per share during the next fiscal year.
Esperion Therapeutics Inc (NASDAQ: ESPR) Trading Performance Indicators
Check out the current performance indicators for Esperion Therapeutics Inc (ESPR). In the past quarter, the stock posted a quick ratio of 0.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Esperion Therapeutics Inc (ESPR)
Compared to the last year’s volume of 5.33 million, its volume of 4.15 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 67.51%.
During the past 100 days, Esperion Therapeutics Inc’s (ESPR) raw stochastic average was set at 78.96%, which indicates a significant decrease from 96.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.58, while its 200-day Moving Average is $1.69. Nevertheless, the first resistance level for the watch stands at $2.97 in the near term. At $3.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.16. If the price goes on to break the first support level at $2.78, it is likely to go to the next support level at $2.66. Should the price break the second support level, the third support level stands at $2.59.
Esperion Therapeutics Inc (NASDAQ: ESPR) Key Stats
There are currently 201,623K shares outstanding in the company with a market cap of 671.71 million. Presently, the company’s annual sales total 332,310 K according to its annual income of -51,750 K. Last quarter, the company’s sales amounted to 82,390 K and its income totaled -12,720 K.
